A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
PHASE1RecruitingINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
February 10, 2025
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2026
Conditions
B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG
CAR T cells
chimeric antigen receptor T cells
Trial Locations (1)
102200
RECRUITING
Beijing GoBroad Hospital, Beijing
All Listed Sponsors
lead
Kai Hu
OTHER
NCT06822868 - A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter